Certain LED Lighting Devices, LED Power Supplies, and Components Thereof Institution of Investigation, 51872-51873 [2017-24323]
Download as PDF
51872
Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices
Electronic Document Information
System (EDIS) where the full written
submission can be found.
By order of the Commission.
Issued: November 2, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017–24261 Filed 11–7–17; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1081]
Certain LED Lighting Devices, LED
Power Supplies, and Components
Thereof Institution of Investigation
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that a
complaint was filed with the U.S.
International Trade Commission on
September 21, 2017, under section 337
of the Tariff Act of 1930, as amended,
on behalf of Philips Lighting North
America Corp. of Somerset, New Jersey
and Philips Lighting Holding B.V. of the
Netherlands. Supplements to the
complaint were filed on October 6 and
30, 2017. The complaint alleges
violations of section 337 based upon the
importation into the United States, the
sale for importation, and the sale within
the United States after importation of
certain LED lighting devices, LED power
supplies, and components thereof by
reason of infringement of certain claims
of U.S. Patent No. 6,586,890 (‘‘the ’890
patent’’); U.S. Patent No. 7,038,399 (‘‘the
’399 patent’’); U.S. Patent No. 7,256,554
(‘‘the ’554 patent’’); U.S. Patent No.
7,262,559 (‘‘the ’559 patent’’); and U.S.
Patent No. 8,070,328 (‘‘the ’328 patent’’).
The complaint further alleges that an
industry in the United States exists as
required by the applicable Federal
Statute.
The complainants request that the
Commission institute an investigation
and, after the investigation, issue a
limited exclusion order and cease and
desist orders.
ADDRESSES: The complaint, except for
any confidential information contained
therein, is available for inspection
during official business hours (8:45 a.m.
to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade
Commission, 500 E Street, SW., Room
112, Washington, DC 20436, telephone
(202) 205–2000. Hearing impaired
individuals are advised that information
on this matter can be obtained by
contacting the Commission’s TDD
ethrower on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:26 Nov 07, 2017
Jkt 244001
terminal on (202) 205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at (202) 205–
2000. General information concerning
the Commission may also be obtained
by accessing its internet server at
https://www.usitc.gov. The public
record for this investigation may be
viewed on the Commission’s electronic
docket (EDIS) at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT: The
Office of Docket Services, U.S.
International Trade Commission,
telephone (202) 205–1802.
SUPPLEMENTARY INFORMATION:
Authority: The authority for
institution of this investigation is
contained in section 337 of the Tariff
Act of 1930, as amended, 19 U.S.C. 1337
and in section 210.10 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.10 (2017).
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
November 2, 2017, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain LED lighting
devices, LED power supplies, and
components thereof by reason of
infringement of one or more of claims
14, 22, and 30 of the ’890 patent; claims
1, 2, 4, 5, 7, 8, 17–19, 34, 35, 47, 48, and
58–60 of the ’399 patent; claims 1, 2, 5–
7, 12, 46, 47, and 49–51 of the ’554
patent; claims 6 and 12 of the ’559
patent; and claims 1, 2, 4, 7, and 9 of
the ’328 patent; and whether an
industry in the United States exists as
required by subsection (a)(2) of section
337;
(2) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainant is:
Philips Lighting North America Corp.,
200 Franklin Square Drive, Somerset,
NJ 08873.
Philips Lighting Holding B.V., High
Tech Campus 45, Eindhoven, 5656
AE, Netherlands.
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Feit Electric Company, Inc., 4901 Gregg
Road, Pico Rivera, CA 90660.
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Edgewell Personal Care Brands, LLC, 6
Research Drive, Shelton, CT 06484.
Feit Electric Company, Inc. (China),
Zone B, 2/F, Xinyu Building, No. 17
Huoju East Road, Huli District
Xiamen, China.
Lowe’s Companies, Inc., 1000 Lowe’s
Boulevard, Mooresville, NC 28117.
L G Sourcing, Inc., 1605 Curtis Bridge
Road, North Wilkesboro, NC 28659.
MSi Lighting, Inc., 622 Banyan Trail
Suite 200, Boca Raton, FL 33431.
Satco Products, Inc., 110 Heartland
Boulevard, Brentwood, NY 11717.
Topaz Lighting Corp., 925 Waverly
Avenue, Holtsville, NY 11742.
Wangs Alliance Corporation d/b/a
WAC, Lighting Co., 44 Harbor Park
Drive, Port Washington, NY 11050.
WAC Lighting (Shanghai) Co. Ltd.,
No. 14, Lane 299, Bi Sheng Road,
Zhang Jiang, Pu Dong District,
Shanghai, China 201204.
(3) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
The Office of Unfair Import
Investigations will not participate as a
party in the investigation.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the complaint and the
notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
E:\FR\FM\08NON1.SGM
08NON1
Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices
Issued: November 3, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017–24323 Filed 11–7–17; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–471F]
Established Aggregate Production
Quotas for Schedule I and II Controlled
Substances and Assessment of
Annual Needs for the List I Chemicals
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine for 2018
Drug Enforcement
Administration, Department of Justice.
ACTION: Final order.
AGENCY:
This final order establishes
the initial 2018 aggregate production
quotas for controlled substances in
schedules I and II of the Controlled
Substances Act and the assessment of
annual needs for the list I chemicals
ephedrine, pseudoephedrine, and
phenylpropanolamine.
APPLICABLE DATE: Applicable November
8, 2017.
FOR FURTHER INFORMATION CONTACT:
Michael J. Lewis, Diversion Control
Division, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152, Telephone: (202)
598–6812.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Legal Authority
Section 306 of the Controlled
Substances Act (CSA) (21 U.S.C. 826)
requires the Attorney General to
establish aggregate production quotas
for each basic class of controlled
substance listed in schedules I and II
and for the list I chemicals ephedrine,
pseudoephedrine, and
phenylpropanolamine. The Attorney
General has delegated this function to
the Administrator of the DEA pursuant
to 28 CFR 0.100.
ethrower on DSK3G9T082PROD with NOTICES
Background
The 2018 aggregate production quotas
and assessment of annual needs
represent those quantities of schedule I
and II controlled substances and the list
I chemicals ephedrine,
pseudoephedrine, and
phenylpropanolamine that may be
manufactured in the United States in
2018 to provide for the estimated
medical, scientific, research, industrial
needs of the United States, lawful
export requirements, and the
VerDate Sep<11>2014
17:26 Nov 07, 2017
Jkt 244001
establishment and maintenance of
reserve stocks. These quotas include
imports of ephedrine, pseudoephedrine,
and phenylpropanolamine, but do not
include imports of controlled
substances for use in industrial
processes.
On August 7, 2017, a notice titled
‘‘Proposed Aggregate Production Quotas
for Schedule I and II Controlled
Substances and Assessment of Annual
Needs for the List I Chemicals
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine for 2018’’ was
published in the Federal Register. 82 FR
36830. This notice proposed the 2018
aggregate production quotas for each
basic class of controlled substance listed
in schedules I and II and the 2018
assessment of annual needs for the list
I chemicals ephedrine,
pseudoephedrine, and
phenylpropanolamine. All interested
persons were invited to comment on or
object to the proposed aggregate
production quotas and the proposed
assessment of annual needs on or before
September 6, 2017.
Comments Received
Within the public comment period,
the DEA received seventeen comments
from three DEA-registered
manufacturers regarding sixteen
different schedule I and II controlled
substances and one comment from a
DEA-registered manufacturer regarding
the proposed assessment of annual
needs for the list I chemical
phenylpropanolamine (for conversion).
Commenters stated the proposed
aggregate production quotas for 4anilino-n-phenethyl-4-piperadine
(ANPP), amphetamine (for conversion),
codeine (for sale), diphenoxylate,
fentanyl, gamma hydroxybutyric acid,
hydrocodone (for sale),
lisdexamfetamine, methadone,
methadone-intermediate,
methylphenidate, morphine (for
conversion), morphine (for sale),
oxycodone (for sale), oxymorphone (for
sale), sufentanil, as well as the proposed
assessment of annual needs for
phenylpropanolamine (for conversion),
were insufficient to provide for the
estimated medical, scientific, research,
and industrial needs of the United
States, export requirements, and the
establishment and maintenance of
reserve stocks. These comments were
considered in setting the final 2018
Aggregate Production Quotas as
discussed below.
In addition to these seventeen
comments, the DEA received one
comment from a DEA-registered
manufacturer seeking clarification on
whether DEA considers manufacturing
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
51873
at outsourcing facilities when
determining the Aggregate Production
Quotas. The DEA notes that it is the
responsibility of all DEA-registered
dosage form manufacturers to submit
quota applications by April 1, in order
for their individual business practices to
be considered when the DEA proposes
the Aggregate Production Quota for the
following year. 21 CFR 1303.12(b).
These quota applications and comments
with discrete data regarding the
quantities of the basic classes of
schedule I or II controlled substances
received during the comment period for
the proposed Aggregate Production
Quotas are taken into consideration
before establishing the values presented
in this Final Order. This DEA-registered
manufacturer provided no quantitative
data supporting the position that the
proposed quota for 2018 will adversely
impact outsourcing facilities for DEA to
consider. The DEA also received one
hundred five comments that expressed
concern that DEA’s proposed reduction
of opioids by twenty percent would
adversely impact the availability of pain
relieving prescription drugs for people
with chronic pain. These comments
were general in nature, and raised issues
of specific medical illnesses and
medical treatment, and therefore are
outside of the scope of this Final Order
for 2018. As a result, these one hundred
and six comments did not provide new
discrete data for consideration, and do
not impact the original analysis
involved in establishing the 2018
aggregate production quotas.
Determination of 2018 Aggregate
Production Quotas and Assessment of
Annual Needs
In determining the 2018 aggregate
production quotas and assessment of
annual needs, the DEA has taken into
consideration the above comments
along with the factors set forth in 21
CFR 1303.11 and 21 CFR 1315.11, in
accordance with 21 U.S.C. 826(a), and
other relevant factors, including the
2017 manufacturing quotas, current
2017 sales and inventories, anticipated
2018 export requirements, industrial
use, additional applications for 2018
quotas, as well as information on
research and product development
requirements. Based on all of the above,
the Administrator is adjusting the 2018
aggregate production quotas for 2-(4bromo-2,5-dimethoxyphenyl)-n-(2methoxybenzyl) ethanamine, 3,4,5trimethoxy amphetamine, 4-bromo-2,5dimethoxy-amphetamine, acryl
fentanyl, alfentanil, amobarbital,
methylphenidate, and nabilone, are
warranted. Adjustment to the proposed
assessment of annual needs for
E:\FR\FM\08NON1.SGM
08NON1
Agencies
[Federal Register Volume 82, Number 215 (Wednesday, November 8, 2017)]
[Notices]
[Pages 51872-51873]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-24323]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1081]
Certain LED Lighting Devices, LED Power Supplies, and Components
Thereof Institution of Investigation
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that a complaint was filed with the
U.S. International Trade Commission on September 21, 2017, under
section 337 of the Tariff Act of 1930, as amended, on behalf of Philips
Lighting North America Corp. of Somerset, New Jersey and Philips
Lighting Holding B.V. of the Netherlands. Supplements to the complaint
were filed on October 6 and 30, 2017. The complaint alleges violations
of section 337 based upon the importation into the United States, the
sale for importation, and the sale within the United States after
importation of certain LED lighting devices, LED power supplies, and
components thereof by reason of infringement of certain claims of U.S.
Patent No. 6,586,890 (``the '890 patent''); U.S. Patent No. 7,038,399
(``the '399 patent''); U.S. Patent No. 7,256,554 (``the '554 patent'');
U.S. Patent No. 7,262,559 (``the '559 patent''); and U.S. Patent No.
8,070,328 (``the '328 patent''). The complaint further alleges that an
industry in the United States exists as required by the applicable
Federal Statute.
The complainants request that the Commission institute an
investigation and, after the investigation, issue a limited exclusion
order and cease and desist orders.
ADDRESSES: The complaint, except for any confidential information
contained therein, is available for inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S.
International Trade Commission, 500 E Street, SW., Room 112,
Washington, DC 20436, telephone (202) 205-2000. Hearing impaired
individuals are advised that information on this matter can be obtained
by contacting the Commission's TDD terminal on (202) 205-1810. Persons
with mobility impairments who will need special assistance in gaining
access to the Commission should contact the Office of the Secretary at
(202) 205-2000. General information concerning the Commission may also
be obtained by accessing its internet server at https://www.usitc.gov.
The public record for this investigation may be viewed on the
Commission's electronic docket (EDIS) at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT: The Office of Docket Services, U.S.
International Trade Commission, telephone (202) 205-1802.
SUPPLEMENTARY INFORMATION:
Authority: The authority for institution of this investigation is
contained in section 337 of the Tariff Act of 1930, as amended, 19
U.S.C. 1337 and in section 210.10 of the Commission's Rules of Practice
and Procedure, 19 CFR 210.10 (2017).
Scope of Investigation: Having considered the complaint, the U.S.
International Trade Commission, on November 2, 2017, ordered that--
(1) Pursuant to subsection (b) of section 337 of the Tariff Act of
1930, as amended, an investigation be instituted to determine whether
there is a violation of subsection (a)(1)(B) of section 337 in the
importation into the United States, the sale for importation, or the
sale within the United States after importation of certain LED lighting
devices, LED power supplies, and components thereof by reason of
infringement of one or more of claims 14, 22, and 30 of the '890
patent; claims 1, 2, 4, 5, 7, 8, 17-19, 34, 35, 47, 48, and 58-60 of
the '399 patent; claims 1, 2, 5-7, 12, 46, 47, and 49-51 of the '554
patent; claims 6 and 12 of the '559 patent; and claims 1, 2, 4, 7, and
9 of the '328 patent; and whether an industry in the United States
exists as required by subsection (a)(2) of section 337;
(2) For the purpose of the investigation so instituted, the
following are hereby named as parties upon which this notice of
investigation shall be served:
(a) The complainant is:
Philips Lighting North America Corp., 200 Franklin Square Drive,
Somerset, NJ 08873.
Philips Lighting Holding B.V., High Tech Campus 45, Eindhoven, 5656 AE,
Netherlands.
(b) The respondents are the following entities alleged to be in
violation of section 337, and are the parties upon which the complaint
is to be served:
Feit Electric Company, Inc., 4901 Gregg Road, Pico Rivera, CA 90660.
Edgewell Personal Care Brands, LLC, 6 Research Drive, Shelton, CT
06484.
Feit Electric Company, Inc. (China), Zone B, 2/F, Xinyu Building, No.
17 Huoju East Road, Huli District Xiamen, China.
Lowe's Companies, Inc., 1000 Lowe's Boulevard, Mooresville, NC 28117.
L G Sourcing, Inc., 1605 Curtis Bridge Road, North Wilkesboro, NC
28659.
MSi Lighting, Inc., 622 Banyan Trail Suite 200, Boca Raton, FL 33431.
Satco Products, Inc., 110 Heartland Boulevard, Brentwood, NY 11717.
Topaz Lighting Corp., 925 Waverly Avenue, Holtsville, NY 11742.
Wangs Alliance Corporation d/b/a WAC, Lighting Co., 44 Harbor Park
Drive, Port Washington, NY 11050.
WAC Lighting (Shanghai) Co. Ltd., No. 14, Lane 299, Bi Sheng Road,
Zhang Jiang, Pu Dong District, Shanghai, China 201204.
(3) For the investigation so instituted, the Chief Administrative
Law Judge, U.S. International Trade Commission, shall designate the
presiding Administrative Law Judge.
The Office of Unfair Import Investigations will not participate as
a party in the investigation.
Responses to the complaint and the notice of investigation must be
submitted by the named respondents in accordance with section 210.13 of
the Commission's Rules of Practice and Procedure, 19 CFR 210.13.
Pursuant to 19 CFR 201.16(e) and 210.13(a), such responses will be
considered by the Commission if received not later than 20 days after
the date of service by the Commission of the complaint and the notice
of investigation. Extensions of time for submitting responses to the
complaint and the notice of investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely response to each
allegation in the complaint and in this notice may be deemed to
constitute a waiver of the right to appear and contest the allegations
of the complaint and this notice, and to authorize the administrative
law judge and the Commission, without further notice to the respondent,
to find the facts to be as alleged in the complaint and this notice and
to enter an initial determination and a final determination containing
such findings, and may result in the issuance of an exclusion order or
a cease and desist order or both directed against the respondent.
By order of the Commission.
[[Page 51873]]
Issued: November 3, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017-24323 Filed 11-7-17; 8:45 am]
BILLING CODE 7020-02-P